Intellia Therapeutics said on Wednesday that the U. Food and Drug Administration has placed a clinical hold on its two ...
Food and Drug Administration has placed a clinical hold on Intellia Therapeutics' two late-stage trials testing an ...
This mental health condition, sometimes called skin picking or excoriation disorder, involves picking the skin so much that ...
The long-awaited Gene Technology Bill has stalled because New Zealand First won’t support it as it stands. The sticking point ...
Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...
Tom Golisano donates a record $50 million to University of Maryland Medical System for children's hospital enhancements.
The University of Maryland Children's Hospital received a $50 million gift from philanthropist Tom Golisano — the largest ...
You wouldn't know it watching Lilly Lou go through life with her independence, spirit, strong will, mobility, kindness, ...
The company raised the midpoint of its revenue growth guidance, now expecting 14% to 15.5% organic non-COVID growth or 12% to 13.5% organic revenue growth for 2025, with the midpoint of both ...
CARsgen Therapeutics Holdings Ltd. (($HK:2171)) announced an update on their ongoing clinical study. CARsgen Therapeutics Holdings Ltd. has ...
The cell therapy field has long held a transformative ambition: to create "off-the-shelf" treatments that can reach not just ...
Last month, “historic positive results” from uniQure’s gene therapy snapped the Huntington’s community out of years of failure. As the biotech prepares to submit for FDA approval, BioSpace looks at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback